Trials / Completed
CompletedNCT00165711
The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- —
Summary
Patients who fit the inclusion criteria are admitted into the study. They are given 3 IV injection of MBL in the first week and one tablet three times a day for 16 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mecobalamin |
Timeline
- Start date
- 2003-03-01
- First posted
- 2005-09-14
- Last updated
- 2019-02-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00165711. Inclusion in this directory is not an endorsement.